Evaluation of Candidates Sample Clauses

Evaluation of Candidates. 1. The Agency may hire from among properly ranked and certified candidates for promotion; or any other appropriate source.
AutoNDA by SimpleDocs
Evaluation of Candidates. 1. Applications may be evaluated by a subject matter expert, a rating panel or a human resources representative. Regardless of the evaluator, ratings must be based solely on the application material submitted by the applicant. If an automated staffing system is used to qualify, rate and/or rank applicants, then a human resources representative will conduct a quality review before the rating is finalized. When a quality review is conducted for an automated rating, an adjustment will only be made in the event that an applicant’s answer(s) to the automated question(s) are not consistent with the applicant’s resume or other documentation provided in the promotion package.
Evaluation of Candidates. 1. The Agency will provide Area 1 applicants priority consideration over non-employee applicants to compete for all vacancies. When the minimum Area 1 applicant threshold in Paragraph 3 (below) is met, the Agency cannot consider other applicants until the Area 1 candidates have been duly considered, to include being interviewed IAW Section 15.6:
Evaluation of Candidates. Applications for promotion will be in writing as prescribed by the Personnel Office. Personnel, in consultation with the Department Manager, will assign each qualified applicant points in each of six (6) areas outlined below. Selecting/recommending officials will consider candidates on a list prepared by Personnel showing the rating of candidates.
Evaluation of Candidates. All job applications for positions on this base will be screened for basic qualifications by HRO and then returned to this base for rating, ranking, and selection, in accordance with the Merit Placement Plan. This would allow personnel who are more familiar with the requirements of the job to evaluate the skills and knowledge of the basically qualified applicants. The following statement will be included on vacancy announcements: “Individual must meet all the military requirements of the position without creating a grade- inversion, as determined by the supervisor.”
Evaluation of Candidates. The Selection Committee shall evaluate candidates in regard to subject area knowledge and competence, teaching and communication skills, commitment to professional growth and service, potential for effective participation in the College’s governance and sensitivity to and understanding of the diverse academic, socioeconomic, cultural, disabled and ethnic backgrounds of the District’s students. The Selection Committee may require candidates to submit portfolios. These may include, but are not limited to, recorded teaching demonstrations, publications, websites and other creative work. Selection Committees are encouraged to be creative in establishing interviewing and evaluation techniques that meet the specific and unique requirements of the position being hired. The overriding criterion is that all candidates be treated equitably in the evaluation process. Equity is a key word. Candidates should receive the same kind of treatment, which might not necessarily be "equal". A committee is hiring a colleague in addition to a teacher, and this should be kept in mind when designing the interview process and/or questions. Follow-up questions during an interview may be needed to fully understand the candidate, though sometimes these should be limited in order to ensure there is enough time to complete an interview. The Selection Committee shall decide in advance how the questions may be handled.
Evaluation of Candidates. A. In any instance where seven (7) or more applicants for each position to be filled (regardless of number of grade levels advertised) meet basic eligibility requirements, a Merit Promotion Panel will be convened in accordance with the requirements of the USDA and FCIC Merit Promotion Plans, and this Article.
AutoNDA by SimpleDocs
Evaluation of Candidates. The State shall evaluate the resumes and references of submitted candidates. Selection shall be based on a best value evaluation using the criteria identified in the SOW and the rate provided by the contractor. The State reserves the right to refuse any or all individuals presented by the contractor(s). The State will evaluate the resumes of the submitted candidates and communicate its initial feedback (Reject/Interview) within 7 business days of receipt for regular requests and within 2 business days of receipt for urgent requests. The State may contact the contractor to request an interview with the candidate. The contractor must be responsible for setting up all interviews. At the State’s discretion, this initial interview may be conducted over the telephone. The State will attempt to pre-screen candidates over the phone. The State may, at its discretion, request a face-to-face interview. The State shall bear no cost for the time and travel of the candidate for attendance at the interview. After selecting the candidate(s), the State will notify contractor regarding its selection within 2-3 days. The contractor shall provide the results of a criminal background check and any additional screening required by a specific SOW to meet agency requirements. The contractor shall provide verification of a candidate’s permission to work in the United States.

Related to Evaluation of Candidates

  • Evaluation of Students A teacher shall maintain the right and responsibility to determine grades and other evaluation of students within the grading policies of the District based upon professional judgment of available criteria pertinent to any given subject area or activity for which the teacher is responsible. No grade or evaluation shall be changed without consultation with the teacher.

  • Formation and Composition The Parties to this agreement will maintain a Joint Administration and Dispute Resolution Committee (JADRC) consisting of five (5) representatives of the employers and five (5) representatives of the Provincial Bargaining Council.

  • Evaluation Cycle Goal Setting and Development of the Educator Plan

  • Evaluation Criteria 5.2.1. The responses will be evaluated based on the following: (edit evaluation criteria below as appropriate for your project)

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Separation of Components The SOFTWARE PRODUCT is licensed as a single product. Its component parts may not be separated for use on more than one computer.

  • Technical Feasibility of String While ICANN has encouraged and will continue to encourage universal acceptance of all top-­‐level domain strings across the Internet, certain top-­‐level domain strings may encounter difficulty in acceptance by ISPs and webhosters and/or validation by web applications. Registry Operator shall be responsible for ensuring to its satisfaction the technical feasibility of the TLD string prior to entering into this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.